Citations (26)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
F. Mendes, C. Antunes, A. M. Abrantes, A. C. Gonçalves, I. Nobre-Gois, A. B. Sarmento, M. F. Botelho & M. S. Rosa. (2015) Lung cancer: the immune system and radiation. British Journal of Biomedical Science 72:2, pages 78-84.
Read now
Read now
Yan Feng & Patrick C Ma. (2012) MET targeted therapy for lung cancer: clinical development and future directions. Lung Cancer: Targets and Therapy 3, pages 53-67.
Read now
Read now
Articles from other publishers (24)
Waleed Hassan Almalki. (2023) Beyond the genome: lncRNAs as regulators of the PI3K/AKT pathway in lung cancer. Pathology - Research and Practice 251, pages 154852.
Crossref
Crossref
Anasse Nounsi, Joseph Seitlinger, Charlotte Ponté, Julien Demiselle, Ysia Idoux-Gillet, Erwan Pencreach, Michèle Beau-Faller, Véronique Lindner, Jean-Marc Balloul, Eric Quemeneur, Hélène Burckel, Georges Noël, Anne Olland, Florence Fioretti, Pierre-Emmanuel Falcoz, Nadia Benkirane-Jessel & Guoqiang Hua. (2023) Patient-Derived Tumoroid for the Prediction of Radiotherapy and Chemotherapy Responses in Non-Small-Cell Lung Cancer. Biomedicines 11:7, pages 1824.
Crossref
Crossref
Jolanta Smok-Kalwat, Paulina Mertowska, Sebastian Mertowski, Konrad Smolak, Aleksandra Kozińska, Filip Koszałka, Wojciech Kwaśniewski, Ewelina Grywalska & Stanisław Góźdź. (2023) The Importance of the Immune System and Molecular Cell Signaling Pathways in the Pathogenesis and Progression of Lung Cancer. International Journal of Molecular Sciences 24:2, pages 1506.
Crossref
Crossref
Hélène Lê, Joseph Seitlinger, Véronique Lindner, Anne Olland, Pierre-Emmanuel Falcoz, Nadia Benkirane-Jessel & Eric Quéméneur. (2022) Patient-Derived Lung Tumoroids—An Emerging Technology in Drug Development and Precision Medicine. Biomedicines 10:7, pages 1677.
Crossref
Crossref
Shadab Md, Nabil A. Alhakamy, Shahid Karim, Gamal A Gabr, Mohammad Kashif Iqubal & Samar S. A. Murshid. (2021) Signaling Pathway Inhibitors, miRNA, and Nanocarrier-Based Pharmacotherapeutics for the Treatment of Lung Cancer: A Review. Pharmaceutics 13:12, pages 2120.
Crossref
Crossref
Nabil A. Alhakamy, Osama A. A. Ahmed, Shadab Md & Usama A. Fahmy. (2021) Mastoparan, a Peptide Toxin from Wasp Venom Conjugated Fluvastatin Nanocomplex for Suppression of Lung Cancer Cell Growth. Polymers 13:23, pages 4225.
Crossref
Crossref
Shadab Md, Samaa T. Abdullah, Nabil A. Alhakamy, Ahmad Bani-Jaber, Ammu Kutty Radhakrishnan, Shahid Karim, Naiyer Shahzad, Gamal A. Gabr, Abdulmohsin J. Alamoudi & Waleed Y. Rizg. (2021) Ambroxol Hydrochloride Loaded Gastro-Retentive Nanosuspension Gels Potentiate Anticancer Activity in Lung Cancer (A549) Cells. Gels 7:4, pages 243.
Crossref
Crossref
Jun-O Jin, Nidhi Puranik, Quyen Thu Bui, Dhananjay Yadav & Peter Chang-Whan Lee. (2021) The Ubiquitin System: An Emerging Therapeutic Target for Lung Cancer. International Journal of Molecular Sciences 22:17, pages 9629.
Crossref
Crossref
Mohamed A. Elkady, Ahmed S. Doghish, Ahmed Elshafei & Mostafa M. Elshafey. (2021) MicroRNA-567 inhibits cell proliferation and induces cell apoptosis in A549 NSCLC cells by regulating cyclin-dependent kinase 8. Saudi Journal of Biological Sciences 28:4, pages 2581-2590.
Crossref
Crossref
Gurjit Kaur Bhatti, Paras Pahwa, Anshika Gupta, Umashanker Navik & Jasvinder Singh Bhatti. 2021. Targeting Cellular Signalling Pathways in Lung Diseases. Targeting Cellular Signalling Pathways in Lung Diseases
217
239
.
Sinan Uğur Umu, Hilde Langseth, Andreas Keller, Eckart Meese, Åslaug Helland, Robert Lyle & Trine B. Rounge. (2020) A 10‐year prediagnostic follow‐up study shows that serum RNA signals are highly dynamic in lung carcinogenesis. Molecular Oncology 14:2, pages 235-247.
Crossref
Crossref
Afeez Adekunle Ishola, Anita Silas La’ah, Hung Dinh Le, Viet Quoc Nguyen, Yi-Ping Yang, Shih-Jie Chou, Hsiao-Yun Tai, Chian-Shiu Chien & Mong-Lien Wang. (2020) Non-coding RNA and lung cancer progression. Journal of the Chinese Medical Association 83:1, pages 8-14.
Crossref
Crossref
Sanket Bapat, Saim Momin & Renu Vyas. 2020. Advances in Bioengineering. Advances in Bioengineering
3
28
.
Suchisnigdha Datta & Dona Sinha. (2019) EGCG maintained Nrf2-mediated redox homeostasis and minimized etoposide resistance in lung cancer cells. Journal of Functional Foods 62, pages 103553.
Crossref
Crossref
Juan Wang, Shumei Ma, Xiuhua Chen, Sanqi Zhang, Zhiyong Wang & Qibing Mei. (2018) The novel PI3K inhibitor S1 synergizes with sorafenib in non-small cell lung cancer cells involving the Akt-S6 signaling. Investigational New Drugs 37:5, pages 828-836.
Crossref
Crossref
Barbara J. S. Sanderson, Karen Burke Da Silva & Mahnaz Ramezanpour. 2016. The Cnidaria, Past, Present and Future. The Cnidaria, Past, Present and Future
669
681
.
YA-NIAN ZHANG, XIAO-YANG WU, NING ZHONG, JUN DENG, LU ZHANG, WEN CHEN, XING LI & CHONG-JUN ZHONG. (2014) Stimulatory effects of sorafenib on human non-small cell lung cancer cells in vitro by regulating MAPK/ERK activation. Molecular Medicine Reports 9:1, pages 365-369.
Crossref
Crossref
Ana Zovko, Kristina Viktorsson, Rolf Lewensohn, Katja Kološa, Metka Filipič, Hong Xing, William Kem, Laura Paleari & Tom Turk. (2013) APS8, a Polymeric Alkylpyridinium Salt Blocks α7 nAChR and Induces Apoptosis in Non-Small Cell Lung Carcinoma. Marine Drugs 11:7, pages 2574-2594.
Crossref
Crossref
KE-KANG SUN, CHENG JI, XING LI, LU ZHANG, JUN DENG, NING ZHONG & XIAO-YANG WU. (2013) Overexpression of high mobility group protein B1 correlates with the proliferation and metastasis of lung adenocarcinoma cells. Molecular Medicine Reports 7:5, pages 1678-1682.
Crossref
Crossref
Hilary S. Serracino, Wilbur A. Franklin & Dara L. Aisner. (2012) Molecular Pathology of Non–Small Cell Lung Cancer. Surgical Pathology Clinics 5:4, pages 903-918.
Crossref
Crossref
Yan Feng, Praveena S. Thiagarajan & Patrick C. Ma. (2012) MET Signaling: Novel Targeted Inhibition and Its Clinical Development in Lung Cancer. Journal of Thoracic Oncology 7:2, pages 459-467.
Crossref
Crossref
Jill E. Larsen, Tina Cascone, David E. Gerber, John V. Heymach & John D. Minna. (2011) Targeted Therapies for Lung Cancer. The Cancer Journal 17:6, pages 512-527.
Crossref
Crossref
. (2011) Current World Literature. Current Opinion in Pulmonary Medicine 17:4, pages 292-295.
Crossref
Crossref
Tapan K Mukherjee, Karan Paul & Srirupa Mukhopadhyay. (2011) Cell signaling molecules as drug targets in lung cancer: an overview. Current Opinion in Pulmonary Medicine 17:4, pages 286-291.
Crossref
Crossref